Register Login

Thrombophilia

Webinar: Rare Thrombotic Response to a SARS-CoV-2 Vaccine

Please join us for a compelling discussion about the rare, unusual thrombotic events that develop in association with thrombocytopenia approximately one to two weeks after vaccination with a SARS-CoV-2 vaccine. This incidence of thrombocytopenia is mediated by platelet-activating antibodies against platelet-factor 4, without any exposure to heparin, and it mimics heparin-induced thrombocytopenia. Don’t miss this […]
read more

VITT Mechanism Nature Preview

Here is a research article that was rushed to print in the July 7, 2021 Nature that describes the precise pathophysiology of vaccine-induced immune thrombotic thrombocytopenia [VITT]. VITT is the critical 1/60,000 incidence adverse event associated with the adenoviral vector employed in the Astra-Zeneca and Johnson and Johnson vaccines, among others. VITT resembles heparin-induced thrombocytopenia […]
read more

July, 2021 Quick Question: Covid Inflammatory Cell

On June 30, 2021, I [Geo] presented “Covid-coag Controversies, What is Immuno-Thrombo-Inflammation” at the Joint Annual Meeting of the American Society for Clinical Laboratory Science, the Association of Genetic Technologists, and the Society of Armed Forces Medical Laboratory Scientists in Louisville, Kentucky. My handout for the meeting is attached. In follow-up, our July Quick Question […]
read more